Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:911-917
Published online before print March 29, 2004, doi: 10.1161/01.HYP.0000126439.64838.b9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/5/911    most recent
01.HYP.0000126439.64838.b9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilz, B.
Right arrow Articles by Luft, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilz, B.
Right arrow Articles by Luft, F. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
*High Blood Pressure
*Obesity
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Obesity
Right arrow Remodeling
Right arrow Myocardial cardiomyopathy disease

(Hypertension. 2004;43:911.)
© 2004 American Heart Association, Inc.


Hypertension Grand Rounds

Obesity and Hypertension-Induced Restrictive Cardiomyopathy

A Harbinger of Things to Come

Bernhard Pilz; Jan-Hinrich Bräsen; Wolfgang Schneider; Friedrich C. Luft

From the Medical Faculty of the Charité (B.P., F.C.L.), Intensive Care Unit, Franz Volhard Clinic and Department of Pathology (J.-H.B., W.S.), HELIOS Klinikum, Berlin, Germany.

Correspondence to Dr Friedrich C. Luft, Franz Volhard Clinic, Wiltberg Strasse 50, 13125 Berlin, Germany. E-mail luft@fvk-berlin.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Congestive heart failure (CHF) is the inability of the heart to deliver a sufficient oxygen supply to meet the metabolic demands of the tissues at normal filling pressures, both at rest and during exercise. CHF may arise from reduced inotropy, volume overload, pressure overload, or reduced diastolic dilatation.1 Long-standing hypertension causes CHF by increased pressure overload. With time’s passage, pressure overload induces expression of proto-oncogenes (such as c-fos, c-myc, c-jun, and others) that foster myocardial hypertrophy. Hypertrophy entails an increase in the size of individual muscle cells and the overall muscle mass. However, the heart developing hypertrophy under these conditions is limited because the heart operates at a lower inotropic state. Furthermore, structural and biochemical changes occur that have long-term deleterious effects, notably dilatation. Chronic pressure overload is thus accompanied by progressive growth abnormalities and apoptotic cell death.2 The condition has been termed the "cardiomyopathy of overload."3 The heart’s adaptation to overload is wide, perhaps because hypertension itself is heterogeneous. For instance, hypertension is strongly associated with obesity that has its own blood pressure-independent effects on the heart. In young obese persons, subclinical left ventricular diastolic dysfunction is present in all grades of isolated obesity, whereas systolic function is actually increased.4 How such persons present clinically 40 years later is unclear, but because large segments of society now qualify as obese, the topic is of major concern.


*    Presentation of the Case
 
A 65-year-old woman was transferred to our intensive care unit because of heart and renal failure. Three months before admission, she had . . . [Full Text of this Article]